Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlliance Pharma Share News (APH)

Share Price Information for Alliance Pharma (APH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 34.90
Bid: 34.80
Ask: 35.15
Change: -0.10 (-0.29%)
Spread: 0.35 (1.006%)
Open: 35.00
High: 35.20
Low: 34.25
Prev. Close: 35.00
APH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS UPDATES: MP Evans dividend outlook bright; ScS share buyback

Tue, 22nd Mar 2022 21:01

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Sabre Insurance Group PLC - Surrey, England-based motor insurance underwriter - Gross written premium in 2021 falls to GBP169.3 million from GBP173.2 million in 2020 and pretax profit declines to GBP37.2 million from GBP49.1 million. Says it maintained disciplined approach to pricing throughout the year, with rate increases in-line with, or ahead of, expected claims costs. "After several years of gritting our teeth and sticking rigorously to our 'profitability over volume' strategy, our discipline is paying off, we have turned the page as we enter 2022, and are now entering a far more exciting chapter," says Chief Executive Geoff Carter. Says it has seen seen positive premium momentum coming into 2022 and has been able to apply "significant" price increases. "We would therefore anticipate significant year-on-year gross written premium growth whilst continuing to deliver a COR towards the upper end of our target COR range," firm says. Dividend for 2021 falls to 13.0p from 16.0p in 2020.

----------

MP Evans Group PLC - producer of palm oil in Indonesia - Revenue for 2021 rises to USD276.6 million from USD174.5 million in 2020, while pretax profit jumps to USD112.5 million from USD28.4 million. "2021 has been an excellent year for the group. Crop and production have risen further in line with our long-term strategic plans, whilst the palm-oil market has gone from strength to strength," says Executive Chair Peter Hadsley-Chaplin. Recommends final dividend of 25p, taking total ordinary payout for year to 35p and, in addition, firm paid a dividend 5p dividend in February. "The board intends, wherever possible, to continue the group's long-term trend of increasing dividends, which have accelerated in recent years. The board believes that the projected increases in both crop and production form a sound basis for further dividend increases," it says.

----------

ScS Group PLC - Sunderland-based retailer of furniture and flooring - Revenue for half-year to January 29 declines 16% to GBP145.9 million from GBP173.9 million, with result slightly behind the GBP152.0 million generated two years ago in a pre-pandemic period. Firm swings to pretax loss of GBP3.6 million in the half from profit of GBP17.7 million year-on-year. "During the period increased lead times for product due to supply chain disruption impacted delivered gross sales, revenue and profitability but has enabled the group to build a strong order book. This supports the group's expectation of delivering profitable full year results in line with market expectations," firm says. Raises interim dividend by 50% to 4.5 and declares share buyback of up to GBP7 million.

----------

Yu Group PLC - Nottingham, England-based energy supplier - Revenue for 2021 grows to GBP155.4 million from GBP101.5 million in 2020, and swings to pretax profit of GBP3.4 million from loss of GBP1.5 million. "2021 was a remarkable year and a stellar performance that's seen the group outperform forecasts in terms of profitability, growth and forward looking contracted revenue," says Chief Executive Bobby Kalar. Looking out, firm has "significant confidence" in high revenue growth based on increased forward contract book. "Despite turbulence in the wider external market, we remain strong and focussed on delivering continued profitable and controlled growth," firm adds.

----------

YouGov PLC - London-based research and data analytics company - Revenue for six months to the end of January GBP101.2 million, up 28% on GBP79.0 million a year before. Pretax profit rises 18% to GBP9.2 million from GBP7.8 million. Data Products revenue increases by 31%, Data Services revenue up by 9% and Custom Research revenue up by 39%. "YouGov delivered a record performance in the first half of the current financial year. In addition to accelerated and broad-based growth, we achieved sustained profitability and strong cash generation as we continued to focus on driving long-term shareholder value in line with our strategy," says Chief Executive Stephan Shakespeare. Firm adds that second half has started well and current trading remains slightly ahead of board expectations for full-year.

----------

Accesso Technology Group PLC - Berkshire, England-based provider of software for leisure, entertainment and cultural sectors - Says 2021 performance was "simply outstanding" as revenue jumps to USD124.8 million from USD56.1 million in 2020, and swings to pretax profit of USD12.1 million from loss of USD32.9 million. "We delivered record revenue and record profit during another challenging year in our end markets as they continued to recover at varying levels through the year," says Chief Executive Steve Brown. Says 2022 has started strongly with trading volumes in January and February encouraging. Is "cautiously optimistic" on another year of good progress, though does warn that cost base expected to increase as it returns to normal staffing levels.

----------

Kape Technologies PLC - Isle of Man-based digital security and privacy software provider - Revenue for 2021 exceeds management forecasts, rising 89% to USD230.7 million from USD122.2 million in 2020. Pretax profit jumps to USD32.6 million from USD7.3 million. "In 2021, we achieved record customer growth, providing further evidence that our products remain both compelling and highly innovative, and, more importantly, our customers continue to utilise our services for many years," says Chief Executive Ido Erlichman. Says firm has continued this momentum into 2022 and is positive on prospects. Is confident of achieving forecasts announced at time of ExpressVPN acquisition of 2022 revenue of between USD610 million and USD 624 million and pro forma adjusted earnings before interest, tax, depreciation and amortisation of between USD166 million and USD172 million. "The significant progress that was delivered during 2021 has provided Kape with the solid foundations to further extend our reach across the digital privacy and security market in 2022 and beyond," company says.

----------

Real Estate Investors PLC - Midlands, UK-focused real estate investment trust - Revenue for 2021 dips to GBP16.0 million from GBP16.4 million, though firm swings to pretax profit of GBP13.9 million from loss of GBP20.2 million in 2020. Firm boosted by GBP5.0 million gain on change in fair value of investment properties, versus hit of GBP27.9 million the year before. EPRA net tangible assets stand at 58.8p at end of 2021, up from 55.2p at end of 2020. Dividend for year is 3.0625p, up 2.1%.

----------

Online Blockchain PLC - Ongar, England-based blockchain research and development company - Revenue for six months to end of December GBP24,000, down from GBP56,000 a year before. Pretax loss widens to GBP468,000 from GBP76,000. Says ADVFN PLC is performing well, with revenue flat at GBP4.2 million in the period. "As you may have seen, I have stepped down as a director of ADVFN PLC which remains an important investment of Online Blockchain PLC. It is clear that subsequent to ongoing corporate activity around ADVFN, that ADVFN will experience an accelerate pace of change which we will work hard to ensure is positive," says Chief Executive Clement Chambers. Chambers co-founded ADVFN alongside Chair Michael Hodges.

----------

Schroder British Opportunities Trust PLC - provides fresh equity capital to growing small to mid-sized British businesses - Net asset value per share 112.72p at end of 2021, up from 108.44p at June 30. Says this growth of 3.9% in the period was marginally behind its declared total return target of 10% per annum, although it remains ahead of this target in the period since IPO in December 2020 with an annualised return of 13.7%.

----------

Harworth Group PLC - Rotherham, South Yorkshire-based land regenerator - EPRA net disposal value per share 197.6p at end of 2021, up from 160.0p a year before. Total return for year 24.6%, which firm notes is its highest figure to date, after return of 3.0% in 2020. Total dividend for year 1.212p, representing 10% underlying growth from 2020. In 2020 firm paid out 1.8p as dividend, but notes that the 2020 final dividend was increased to reflect the cancelled final 2019 dividend. "Our core sectors continue to perform well, but are not immune to wider macroeconomic pressures. Our focus now is on the execution of the strategy, ensuring that, as we work through our plans, the team has the skills and resources to deliver consistently and successfully, sustainably growing the business and delivering returns through the cycle," says Chief Executive Lynda Shillaw.

----------

Pebble Group PLC - Manchester-based technology and services for promotional products industry - Revenue for 2021 rises to GBP115.1 million from GBP82.4 million in 2020, surpassing 2019's figure of GBP107.2 million. Pretax profit jumps to GBP9.3 million from GBP5.0 in 2020. "Facilisgroup and Brand Addition performed well in the year under review, both financially and in building their differentiation in the market," company says. Adds that new financial year has started well and in line with its expectations.

----------

BioPharma Credit PLC - life sciences debt investment trust - Net asset value per share at December 31 99.26 cents, down from 100.37 cents a year before. Pays dividend of 7.29 cents per share in period, ahead of its 7 cent target. "Despite turbulent market conditions our highly resilient business model continued to deliver revenue as expected being uncorrelated from equity market movements and, uniquely for a London listed investment company, derived principally from cash flows from approved life science products," says Pedro Gonzalez de Cosio, chief executive & co-founder of Pharmakon Advisors LP, the investment manager of BioPharma Credit.

----------

Diurnal Group PLC - Cardiff, Wales-based pharmaceutical company focused on hormonal diseases - Revenue for half-year to December 31 rises to GBP2.1 million from GBP1.2 million, but pretax loss widens to GBP9.2 million from GBP5.3 million. This is largely due to higher research & development expenditure. In early March, firm was "disappointed" to receive the Scottish Medicines Consortium decision not to recommend Efmody for automatic reimbursement in Scotland, which it warns will impact near-term revenue in the UK. "The company's initial assessment of the impact of the recent SMC decision is that, despite continued strong growth (expected to be in excess of 100% for the 12-month period ended 30 June 2022), near-term sales expectations for Efmody are unlikely to be met and that further funding will be required to reach profitability," it says.

----------

Fintel PLC - Huddersfield, England-based technology and support for retail financial services sector - Revenue for 2021 rises to GBP63.9 million from GBP61.0 million and pretax profit nearly doubles at GBP19.9 million from GBP10.2 million. Makes GBP4.3 million gain on sale of subsidiary and GBP3.5 million on sale of operations. "2022 has started positively. Trading has been strong and in line with the board's expectations. We continue to make rapid progress on our strategic delivery and are confident that the company is in a strong position for further growth," it says. Proposes final dividend of 2p per share, resulting in full-year dividend of 3p, up from 2.85p in 2020.

----------

IQGeo Group PLC - Cambridge-based geospatial productivity and collaboration software company focused on the telecoms and utility industries - Revenue for 2021 rises to GBP13.8 million from GBP9.2 million in 2020, and pretax loss narrows to GBP2.7 million from GBP4.4 million. Says GBP3.4 million of new annual recurring revenue added in the year, up from GBP1.4 million in 2020. "We are very pleased to report that we have come out ahead of our own expectations for the financial year and made real progress towards our aim of building a high recurring revenue software business," says Chief Executive Richard Petti. Expects adjusted earnings before interest, tax, depreciation and amortisation and cash flow break even during 2022. Adjusted Ebitda loss for 2021 was GBP800,000, narrowed from GBP2.5 million in 2020.

----------

Princess Private Equity Holding Ltd - invests in private equity and private debt investments - Net asset value stands at EUR15.26 per share at end of 2021, up 19% over the year. Princess paid a total dividend of EUR0.67 per share during the year, in line with previous guidance to distribute 5% of opening NAV for each financial year. For 2022, the company intends to maintain this 5% distribution level. Realisations amounted to EUR462.5 million in the year and investment activity totalled EUR342.4 million

----------

Alliance Pharma PLC - Chippenham, England-based distributor of consumer healthcare brands and prescription medicines - Revenue for 2021 grows to GBP163.2 million from GBP129.8 million in 2020, and pretax profit improves to GBP18.2 million from GBP13.0 million. Says strong overall revenue growth driven by Consumer Healthcare, which saw see-through revenue grow 31% to GBP121.8 million. Firm says 2022 has started well. Expects increased growth from Nizoral in 2022 and sales growth acceleration for Amberen. "Our clear focus on the core Consumer Healthcare business in addition to our well-established, scalable platform across EMEA, APAC and the US, should support significant organic growth this year and beyond," company says.

----------

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
22 Apr 2024 11:58

EARNINGS: Lok'n Store has "positive but muted" growth as Shurgard bids

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
22 Apr 2024 10:03

Alliance Pharma delays preliminary results

(Sharecast News) - International healthcare group Alliance Pharma announced the postponement of its preliminary results for the year ended 31 December on Monday.

Read more
16 Apr 2024 13:45

UK earnings, trading statements calendar - next 7 days

Wednesday 17 April 
Antofagasta PLCTrading Statement
Brooks Macdonald Group PLCTrading Statement
Entain PLCTrading Statement
Hays PLCTrading Statement
Inspecs Group PLCFull Year Results
Liontrust Asset Management PLCTrading Statement
M Winkworth PLCFull Year Results
Menhaden Resource Efficiency PLCFull Year Results
Rio Tinto PLCTrading Statement
Saga PLCFull Year Results
Thursday 18 April 
AJ Bell PLCTrading Statement
BHP Group LtdTrading Statement
Devolver Digital IncFull Year Results
Dunelm Group PLCTrading Statement
easyJet PLCTrading Statement
Foxtons Group PLCTrading Statement
HydrogenOne Capital Growth PLCFull Year Results
Keystone Law Group PLCFull Year Results
LBG Media PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Rentokil Initial PLCTrading Statement
Segro PLCTrading Statement
Friday 19 April 
888 Holdings PLCTrading Statement
Man Group PLCTrading Statement
Monday 22 April 
Brave Bison Group PLCFull Year Results
Elixirr International PLCFull Year Results
Frenkel Topping Group PLCFull Year Results
South32 LtdQ3 Results
Ten Lifestyle Group PLCHalf Year Results
Tuesday 23 April 
Alliance Pharma PLCFull Year Results
Alphawave IP Group PLCFull Year Results
Anglo American PLCTrading Statement
ASA International Group PLCFull Year Results
Associated British Foods PLCHalf Year Results
Eleco PLCFull Year Results
GB Group PLCTrading Statement
Jupiter Fund Management PLCTrading Statement
Maintel Holdings PLCFull Year Results
Property Franchise Group PLCFull Year Results
Taylor Wimpey PLCTrading Statement
tinyBuild IncFull Year Results
Trellus Health PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
5 Apr 2024 07:39

Alliance Pharma to delay release of 2023 results

(Sharecast News) - Shares in Alliance Pharma slipped on Friday after the healthcare company said that its full-year results would be delayed.

Read more
2 Apr 2024 13:21

UK earnings, trading statements calendar - next 7 days

Wednesday 3 April 
Hilton Food Group PLCFull Year Results
Impax Environmental Markets PLCFull Year Results
Pantheon Infrastructure PLCFull Year Results
Thursday 4 April 
LungLife AI IncFull Year Results
Friday 5 April 
no events scheduled 
Monday 8 April 
Bango PLCFull Year Results
Ferrexpo PLCTrading Statement
Globaltrans Investment PLCFull Year Results
Tuesday 9 April 
Alliance Pharma PLCFull Year Results
CMC Markets PLCTrading Statement
hVIVO PLCFull Year Results
Imperial Brands PLCTrading Statement
JTC PLCFull Year Results
S&U PLCFull Year Results
Ultimate Products PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
5 Feb 2024 14:09

TRADING UPDATES: Alliance Pharma appoints chair; FireAngel sales down

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
5 Feb 2024 09:07

Alliance Pharma names Camillo Pane as chair

(Sharecast News) - Consumer healthcare company Alliance Pharma has appointed Camillo Pane to the role of chairman to "lead the company through its next strategic phase", focusing on organic growth through marketing and innovation.

Read more
31 Jan 2024 10:34

RBC Capital Markets nudges down Alliance Pharma price target

(Sharecast News) - RBC Capital Markets nudged its price target on Alliance Pharma down to 60p from 65p on Wednesday as it said it was rebasing its forecasts as trading normalises.

Read more
31 Jan 2024 09:21

LONDON BROKER RATINGS: Jefferies raises Spirax-Sarco; cuts Victrex

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
29 Jan 2024 11:59

Alliance Pharma reports annual boost in revenue; eyes flat 2024 profit

(Alliance News) - Alliance Pharma PLC on Monday said second-half recovery drove its full-year "record" revenue but noted that it does not expect profit growth in 2024.

Read more
29 Jan 2024 10:51

Alliance Pharma expects no profit growth in 2024

(Sharecast News) - Consumer healthcare group Alliance Pharma has said that 2023 results will be in line with market expectations but said that profits are unlikely to grow this year due to increased investment in sales and marketing.

Read more
24 Oct 2023 09:29

LONDON BROKER RATINGS: Barclays ups Rio Tinto; Liberum likes Indivior

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
28 Sep 2023 09:07

LONDON BROKER RATINGS: Barclays cuts United Utilities and Severn Trent

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
26 Sep 2023 11:53

Alliance Pharma first half profit plunges, stops dividend payout

(Alliance News) - Alliance Pharma PLC on Tuesday said profit plunged in the first half of 2023, despite revenue ticking up, as costs increased, prompting the company to opt against paying out a dividend.

Read more
26 Sep 2023 10:16

Alliance Pharma confident after some first-half setbacks

(Sharecast News) - Consumer healthcare firm Alliance Pharma reported first-half revenue growth for its Kelo-Cote and Nizoral products on Tuesday, meeting the board's expectations.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.